eScreen Inc.

Each year at this time, we look back at the previous year to identify the highs, the lows, and the trends that will shape the future of the medical device industry. In 2012, the theme was headwinds. I

As it did in 2011, the applications of sequencing to clinical diagnostics dominated the news in 2012. ( See Also see " Trends In Diagnostics 2011 " - In Vivo, 24 January, 2012.. ) But unlike a year ag

Device Transactions Medical device companies raised a total of $1.1 billion during the first quarter of 2012, a 40% increase over Q4 2011’s $800 million, and a much stronger start to the year than 201

IN VITRO DIAGNOSTICS Mergers & Acquisitions Alere Inc. eScreen Inc. Point-of-care diagnostics company Alere Inc. has acquired private drugs-of-abuse screening firm eScreen Inc. for $270mm in c